Lyka Labs Limited

BSE:500259 Stock Report

Market Cap: ₹5.3b

Lyka Labs Past Earnings Performance

Past criteria checks 3/6

Lyka Labs has been growing earnings at an average annual rate of 28.1%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 8.8% per year. Lyka Labs's return on equity is 3.2%, and it has net margins of 2.6%.

Key information

28.1%

Earnings growth rate

28.4%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate8.8%
Return on equity3.2%
Net Margin2.6%
Next Earnings Update04 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Lyka Labs makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:500259 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,266333370
30 Jun 241,13473180
31 Mar 241,062-262960
31 Dec 231,020-372660
30 Sep 23873-1592400
30 Jun 23848-1582230
31 Mar 23894-1332040
31 Dec 22964-2541990
30 Sep 221,142-891960
30 Jun 221,6251991950
31 Mar 221,8453891950
31 Dec 211,6545511850
30 Sep 211,5674671800
30 Jun 211,0021261680
31 Mar 21685-1171560
31 Dec 20723-2581540
30 Sep 20638-6471520
30 Jun 20648-6201390
31 Mar 20567-6061550
31 Dec 19731-3991550
30 Sep 19723-181530
30 Jun 19714-371570
31 Mar 19671-571650
31 Mar 18604-1731770
31 Mar 17994-571800
31 Dec 161,503-1682170
30 Sep 161,491-1362110
30 Jun 161,476-91970
31 Mar 161,782532120
31 Dec 151,496863560
30 Sep 151,572221730
30 Jun 151,664-512170
30 Jun 14957-432920

Quality Earnings: 500259 has high quality earnings.

Growing Profit Margin: 500259 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 500259 has become profitable over the past 5 years, growing earnings by 28.1% per year.

Accelerating Growth: 500259 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 500259 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (20.5%).

Return on Equity

High ROE: 500259's Return on Equity (3.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 06:43
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lyka Labs Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution